Login / Signup

Level I axillary dissection in patients with breast cancer and tumor-involved sentinel lymph node after NAC is not sufficient for adequate nodal staging.

Jan ŽateckýOldřich CoufalMiloš HolánekOtakar KubalaMarkéta KepičováJiří GatěkMilan LerchMatúš Peteja
Published in: Turkish journal of surgery (2023)
According to our pilot result, level I axillary dissection is not sufficient in terms of adequate histological nodal staging in breast cancer patients after NAC, and level II axillary dissection should not be omitted.
Keyphrases
  • lymph node
  • sentinel lymph node
  • neoadjuvant chemotherapy
  • transcription factor
  • early stage
  • ultrasound guided
  • clinical trial
  • study protocol